N@N

Market Maker Surveillance Report. LGDI, GILD, QGEN, SLE, CSE, HPCS, Highest Net Buy Volume With Lowest Price Friction For Wedn

^{Published on 2011-12-28 18:00:33 - WOPRAI}
 

December 28, 2011 / M2 PRESSWIRE / BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Wednesday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Wednesday there were 3534 companies with "abnormal" market making, 1762 companies with positive Friction Factors and 5171 companies with negative Friction Factors. Here is a list of the top companies with the highest net buy volume on Wednesday and lowest price Friction (bullish). This means that there was more buying than selling in the stocks and their stock prices rose faster with less Friction. LEGEND INTERNATIONAL HOLDING (OTCBB:LGDI), GILEAD SCIENCES, INC. (NASDAQ:GILD), QIAGEN N.V. (NASDAQ:QGEN), SARA LEE CORP (NYSE:SLE), CAPITALSOURCE INC (NYSE:CSE), (OTC:HPCS). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net .

Market Maker Friction Factor is shown in the chart below:

     Symbol     Change       Percent      Buy Volume      Buy %%       Sell Volume     Sell %%      Net Volume      Friction
     LGDI       $0.071       71.72%       1,300,548       63.02%       757,152         36.69%       543,396         76,535  
     GILD       $0.080       0.20%        3,604,216       57.05%       2,695,212       42.66%       909,004         113,626 
     QGEN       $0.070       0.50%        1,238,763       63.23%       720,412         36.77%       518,351         74,050  
     SLE        $0.010       0.05%        1,160,858       46.79%       660,275         26.61%       500,583         500,583 
     CSE        $0.090       1.36%        1,700,368       45.66%       1,198,294       32.18%       502,074         55,786  
     HPCS       $0.012       40.00%       1,123,000       38.33%       456,500         15.58%       666,500         555,417 

For example, the chart above shows LGDI with a Net Buy Volume of 543,396 shares and a Friction Factor of 76,535 shares. That means that it takes 76,535 more shares of buying than selling to move LGDI higher by one penny. This means the Market Makers are allowing the stock to move up higher as of Wednesday (lower friction). And with one of the highest Net Buy Volumes, the combination of low friction and high net buy volume is bullish.

LEGEND INTERNATIONAL HOLDING (OTCBB:LGDI) - Legend International Holdings, Inc., an exploration stage mining company, engages in the exploration, development, and mining of base metal properties in Australia. The companys principle property includes the Paradise South phosphate project located to the north west of Mt Isa in north-western Queensland. Its landholdings for prospective phosphate, diamonds, and base metals cover 502,949.9 acres in Queensland; and approximately 3,936,528 million acres in the Northern Territory. The company was formerly known as Sundew International, Inc. and changed its name to Legend International Holdings, Inc. in March 2003. Legend International Holdings, Inc. was founded in 2001 and is headquartered in Melbourne, Australia.

GILEAD SCIENCES, INC. (NASDAQ:GILD) - Gilead Sciences, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics for the treatment of life threatening diseases worldwide. Its products include Atripla, Truvada, Viread, Emtriva for the treatment of human immunodeficiency virus infection in adults; Hepsera, an oral formulation for the treatment of chronic hepatitis B; AmBisome, a amphotericin B liposome injection to treat invasive fungal infections; Letairis, an endothelin receptor antagonist for the treatment of pulmonary arterial hypertension; Ranexa for the treatment of chronic angina; Vistide, an antiviral medication for the treatment of cytomegalovirus retinitis in patients with AIDS; and Cayston, an inhaled antibiotic used as a treatment to enhance respiratory systems. The companys products also comprise Tamiflu, an oral antiviral for the treatment and prevention of influenza A and B; Macugen, an intravitreal injection for the treatment of neovascular age-related macular degeneration; and Lexiscan/Rapiscan, an injection used as a pharmacologic stress agent in radionuclide myocardial perfusion imaging. Its products under the Phase III clinical trials consist of Cobicistat, a pharmacoenhancer that is under evaluation as a boosting agent for HIV medicines; Elvitegravir, an oral integrase inhibitor being evaluated as part of combination therapy for HIV; Integrase Single-Tablet, a Quad regimen of elvitegravir, cobicistat, tenofovir disoproxil fumarate, and emtricitabine for the treatment of HIV/AIDS in treatment-naive patients; and Aztreonam for inhalation solution for the treatment of cystic fibrosis patients with Pseudomonas aeruginosa. The companys Phase II clinical trials products comprise Cicletanine, Ranolazine, and Aztreonam, as well as GS 9190, GS 9256, and GS 9451. Its Phase I clinical trial products include GS 7340, GS 5885, GS 6620, GS 9620, and GS 6624. The company was founded in 1987 and is headquartered in Foster City, California.

QIAGEN N.V. (NASDAQ:QGEN) - QIAGEN N.V., through its subsidiaries, provides sample and assay technologies. Sample technologies are used to isolate and process deoxyribonucleic acid, ribonucleic acid, and proteins from biological samples, such as blood or tissue; and assay technologies are used to make such isolated bio-molecules visible. It markets approximately 500 sample and assay products, as well as automated solutions for such consumables. The company provides its products to molecular diagnostics laboratories, academic researchers, pharmaceutical and biotechnology companies, and applied testing customers for purposes, such as forensics, animal or food testing, and pharmaceutical process control. QIAGEN's primary assay technologies include the broadest panels of molecular diagnostic tests available. This panel comprises the digene HPV Test, which is regarded as a gold standard in testing for high-risk types of human papillomavirus, the primary cause of cervical cancer, as well as a broad suite of solutions for infectious disease testing and companion diagnostics. The company markets its products through a sales force and a network of distributors principally in the Americas, Germany, Asia, and Switzerland. It has a collaboration agreement with Genome Diagnostics B.V. for development of tests for applications in prevention and personalized healthcare. QIAGEN was founded in 1986 and is headquartered in Venlo, the Netherlands.

SARA LEE CORP (NYSE:SLE) - Sara Lee Corporation engages in the manufacture and marketing of a range of branded packaged meat, bakery, and beverage products worldwide. Its packaged meat products include hot dogs and corn dogs, breakfast sausages, sandwiches and bowls, smoked and dinner sausages, premium deli and luncheon meats, bacon, beef, turkey, and cooked ham. It also offers fresh and frozen baked products, which comprise bread, buns, bagels, rolls, muffins, specialty bread, frozen pies, cakes, cheesecakes, pastries, and other desserts. In addition, Sara Lee provides roast, ground, and liquid coffee; cappuccinos; lattes; and hot and iced teas, as well as refrigerated dough products. The company sells its products under Hillshire Farm, Ball Park, Jimmy Dean, Sara Lee, State Fair, Earth Grains, Colonial, Rainbo, Holsum, IronKids, Mothers, Sunbeam, Sun-Maid, San Luis Sourdough, Heiners, Douwe Egberts, Senseo, Maison du Caf, Marcilla, Merrild, Pickwick, Caf Caboclo, Caf Pilo, Bimbo, CroustiPate, Ortiz, and BonGateaux brand names. Sara Lee sells its products to mass retailers, supermarkets, mass merchandisers, distributors, restaurants, hospitals, warehouse clubs, national chains, and other institutions through direct sales force and outside brokers. The company was formerly known as Consolidated Foods Corporation and changed its name to Sara Lee Corporation in 1985. Sara Lee Corporation was founded in 1939 and is based in Downers Grove, Illinois.

CAPITALSOURCE INC (NYSE:CSE) - CapitalSource, Inc., a specialized finance company, provides various financial products to small and medium-sized businesses in the United States. It operates through three divisions: Corporate Finance, Healthcare and Specialty Finance, and Structured Finance. The Corporate Finance division provides senior and mezzanine loans to businesses backed by private equity sponsors. The Healthcare and Specialty Finance division offers asset-based revolving lines of credit, first mortgage loans, and senior and mezzanine loans to healthcare businesses and other companies. The Structured Finance division provides commercial and residential real estate lending, and asset-based lending to finance companies. The company was founded in 2000 and is headquartered in Chevy Chase, Maryland.

(OTC:HPCS) -

About BUYINS.NET

BUYINS.NET, www.buyins.net , monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS

Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements"

RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO

INVESTMENTS & TRADING

SqueezeTrigger -- 29 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.

GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.

DISCLAIMER:

BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. BUYINS.NET has not been compensated by any of the above mentioned companies. Past performance is not indicative of future results. Please visit our web site, www.buyins.net , for complete risks and disclosures.

Contact:

BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net www.buyins.net